Verotoxins induce apoptosis in human renal tubular epithelium derived cells

Kidney International

Volumn 53, Issue 6, 1998, Pages 1681-1688

  Taguchi, Tomoko ^b   Uchida, Hiroshi ^b   Kiyokawa, Nobutaka ^b   Mori, Tetsuya ^b   Sato, Norihide ^b   Horie, Hiroshi ^b   Takeda, Tae ^b   Fujimoto, Junichiro ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NONE

Author keywords

ACHN cells; Anemia; Cell death; Hemolytic uremic syndrome; VTEC

Indexed keywords

CD24 ANTIGEN; CYCLOHEXIMIDE; GLOBOTRIAOSYLCERAMIDE; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN;

APOPTOSIS; CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; KIDNEY TUBULE EPITHELIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

EID: 0031780495     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00939.x     Document Type: Conference Paper

References (46)

1. FONG JS, DE CHADAREVIAN JP, KAPLAN BS: Hemolytic uremic syndrome. Current concepts and management. Pediatr Clin North Am 29:835-856, 1982
2. KARMALI MA, PETRIC M, LIM C, FLEMING DC, ARBUS GS, LIOR H: The association between idiopathic hemolytic uremic syndrome and infection by verotoxin producing Escherichia coli. J Infect Dis 151:775-782, 1985
3. OBRIG TG, DEL-VECCHIO PJ, BROWN JE, MORAN TP, ROWLAND BM, JUDGE TK, ROTHMAN SW: Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56:2373-2378, 1988
4. KAPLAN BS, CLEARY TG, OBRIG TG: Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr Nephrol 4:276-283, 1990
5. WADOLKOWSKI EA, SUNG LM, BURRIS JA, SAMUEL JE, O'BRIEN AD: Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 58:3959-3965, 1990
6. LINDGREN SW, MELTON AR, O'BRIEN AD: Virulence of enterohemorrhagic Escherichia coli O91: H21 clinical isolates in an orally infected mouse model. Infect Immun 61:3832-3842, 1993
7. TESH VL, BURRIS JA, OWENS JW, GORDON VM, WADOLKOWSKI EA, O'BRIEN AD, SAMUEL JE: Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392-3402, 1443
8. OOSTERWIJK E, KALISIAK A, WAKKA JC, SCHEINBERG DA, OLD LJ: Monoclonal antibodies against Gala1-4Galb1-4Glc(Pk, CD77) produced with a synthetic glycoconjugate as immunogen: Reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors. Int J Cancer 48:848-854, 1991
9. LINGWOOD CA: Verotoxin-binding in human renal sections. Nephron 66:21-28, 1444
10. TAKEDA T, DOHI S, IGARASHI T, YAMANAKA T, YOSHIYA K, KOBAYASHI N: Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uremic syndrome. J Infect 27:339-341, 1993
11. NODA M, YUTSUDO T, NAKABAYASHI N, HIKAYAMA T, TAKEDA Y: Purification and some properties of Shiga-like toxin from Escherichia coli 0157: H7 that is immunologically identical to Shiga toxin. Microb Pathog 2:339-349, 1987
12. OKU Y, YUTSUDO T, HIRAYAMA T, O'BRIEN AD, TAKEDA Y: Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb Pathog 6:113-122, 1989
13. FUJIMOTO J, ISHIMOTO K, KIYOKAWA N, TANAKA S, ISHII E, HATA J: Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): Evidence that CALLA on ALL cells and granulocytes are structurally related. Hybridoma 7:227-236, 1988
14. KOKAI Y, ISHII Y, KIKUCHI K: Characterization of two distinct antigens expressed on either resting or activated human B cells as defined by monoclonal antibodies. Clin Exp Immunol 64:382-391, 1986
15. ZHANG C, AO Z, SETH A, SCHLOSSMAN SF: A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol 157:3980-3987, 1996
16. HANSEN MB, NIELSEN SE, BERG K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210, 1989
17. MANGENEY M, LINGWOOD CA, TAGA S, CAILLOU B, TURSZ T, WIELS J: Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res 53:5314-5319, 1993
18. GONG J, TRAGANOS F, DARZYNKIEWICZ Z: A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218:314-319, 1994
19. PLATT JL, LEBIEN TW, MICHAEL AF: Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens. J Exp Med 157:155-172, 1983
20. FINA L, MOLGAARD HV, ROBERTSON D, BRADLEY NJ, MONAGHAN P, DELIA D, SUTHERLAND DR, BAKER MA, GREAVES MF: Expression of the CD34 gene in vascular endothelial cells. Blood 75:2417-2426, 1990
21. ISHII E, FUJIMOTO J, TANAKA S, HATA J: Immunohistochemical analysis on normal nephrogenesis and Wilms' tumor using monoclonal antibodies reactive with lymphohaemopoietic antigens. Virchows Arch A 411:315-322, 1987
22. JACEWICZ M, CLAUSEN H, NUDELMAN E, DONOHUE-ROLEF A, KEUSCH GT: Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 163:1391-1404, 1986
23. LINDBERG AA, BROWN JE, STROMBERG N, WESTLING-RYD M, SCHUITZ JE, KARLSSON KA: Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type I. J Biol Chem 262:1779-1785, 1987
24. LINGWOOD CA, LAW H, RICHARDSON S, PETRIC M, BRUNTON JL, DE-GRANDIS S, KARMALI M: Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262:8834-8839, 1987
25. TESH VL, SAMUEL JE, PERERA LP, SHAREFKIN JB, O'BRIEN AD: Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 164:344-352, 1991
26. KAYE SA, LOUISE CB, BOYD B, LINGWOOD CA, OBRIG TG: Shiga toxin-associated hemolytic uremic syndrome: Interleukin-1β enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun 61:3886-3891, 1993
27. OBRIG TG, LOUISE CB, LINGWOOD CA, BOYD B, BARLEY-MALONEY L, DANIEL TO: Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268:15484-15488, 1993
28. OBRIG TG, MORAN TP, BROWN JE: The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J 244:287-294, 1987
29. ENDO Y, TSURUGI K, YUTSUDO T, TAKEDA Y, OGASAWARA T, IGARASHI K: Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171:45-50, 1988
30. SAXENA SK, O'BRIEN AD, ACKERMAN EJ: Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem 264: 596-601, 1989
31. SANDVIG K, VAN DEURS B: Toxin-induced cell lysis: Protection by 3-methyladenine and cycloheximide. Exp Cell Res 200:253-262, 1992
32. INWARD CD, WILLIAMS J, CHANT I, CROCKER J, MILFORD DV, ROSE PE, TAYLOR CM: Verocytotoxin-1 induces apoptosis in vero cells. J Infect 30:213-218, 1995
33. WILLIAMS JM, LEA N, LORD JM, ROBERTS LM, MILFORD DV, TAYLOR CM: Comparison of ribosome-inactivating proteins in the induction of apoptosis. Toxicol Lett 91:121-127, 1997
34. MARTIN SJ, LENNON SV, BONHAM AM, COTTER TG: Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145:1859-1867, 1990
35. BAZAR LS, DEEG HJ: Ultraviolet B-induced DNA fragmentation (apoptosis) in activated T-lymphocytes and Jurkat cells is augmented by inhibition of RNA and protein synthesis. Exp Hematol 20:80-86, 1992
36. PERANDONES CE, ILLERA VA, PECKHAM D, STUNZ LL, ASHMAN RF: Regulation of apoptosis in vitro in mature murine spleen T cells. J Immunol 151:3521-3529, 1993
37. TAGA S, CARLIER K, MISHAL Z, CAPOULADE C, MANGENEY M, LECLUSE Y, COULAUD D, TETAUD C, PRITCHARD LL, TURSZ T, WIELS J: Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lrmphoma cells. Blood 90:2757-2767, 1997
38. PUDYMAITIS A, LINGWOOD CA: Susceptibility to verotoxin as a function of the cell cycle. J Cell Physiol 50:632-639, 1992
39. RICHARDSON SE, KARMALI MA, BECKER LE, SMITH CR: The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19:1102-1108, 1988
40. FITZPATRICK MM, SHAH V, TROMPETER RS, DILLON MJ, BARRATI TM: Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42:951-956, 1992
41. VAN DE KAR NCAJ, SAUERWEIN RW, DEMACKER PN, GRAU GE, VAN HINSBERGH VWM, MONNENS LAH: Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71:309-313, 1995
42. KARPMAN D, ANDREASSON A, THYSELL H, KAPLAN BS, SVANBORG C: Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nyphrol 9:694-699, 1995
43. VAN DE KAR NCAJ, MONNENS LAH, KARMALI MA, VAN HINSBERGH VWM: Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755-2764, 1992
44. TESH VL, RAMEGOWDA B, SAMUEL-JE: Purified Shiga-like toxins induce expression of proinflammalory cytokines from murine peritoneal macrophages. Infect Immun 62:5085-5094, 1994
45. VAN SETTEN PA, MONNENS LAH, VERSTRATEN RGG, VAN DEN HEUVEL LPWJ, VAN HINSBERGH VWM: Effects of verocytotoxin-1 on nonadherent human monocytes: Binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183, 1996
46. POHLMAN TH, HARLAN JM: Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 119:41-52, 1989